BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15138203)

  • 21. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
    Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
    Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus--an alternative to surgery?].
    Orth K; Stanescu A; Rück A; Russ D; Beger HG
    Chirurg; 1999 Apr; 70(4):431-8. PubMed ID: 10354840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
    Barr H
    Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.
    Globe J; Smythe A; Kelty CJ; Reed MW; Brown NJ; Ackroyd R
    J Photochem Photobiol B; 2006 Oct; 85(1):17-22. PubMed ID: 16723253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
    Gossner L; May A; Sroka R; Ell C
    Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study.
    Mörk H; Barth T; Kreipe HH; Kraus M; Al-Taie O; Jakob F; Scheurlen M
    Scand J Gastroenterol; 1998 Nov; 33(11):1130-4. PubMed ID: 9867088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
    Hinnen P; de Rooij FW; Hop WC; Edixhoven A; van Dekken H; Wilson JH; Siersema PD
    J Photochem Photobiol B; 2002 Aug; 68(1):8-14. PubMed ID: 12208031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus.
    Peters FP; Kara MA; Rosmolen WD; Aalders MC; Ten Kate FJ; Bultje BC; Krishnadath KK; Fockens P; van Lanschot JJ; van Deventer SJ; Bergman JJ
    Gastrointest Endosc; 2005 Apr; 61(4):506-14. PubMed ID: 15812401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
    Gossner L; Stolte M; Sroka R; Rick K; May A; Hahn EG; Ell C
    Gastroenterology; 1998 Mar; 114(3):448-55. PubMed ID: 9496934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus.
    Mackenzie GD; Jamieson NF; Novelli MR; Mosse CA; Clark BR; Thorpe SM; Bown SG; Lovat LB
    Lasers Med Sci; 2008 Apr; 23(2):203-10. PubMed ID: 17610005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
    Dunn J; Lovat L
    Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
    Kelty CJ; Ackroyd R; Brown NJ; Brown SB; Reed MW
    Surg Endosc; 2004 Mar; 18(3):452-8. PubMed ID: 14752635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
    Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M
    Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.
    Dulai GS; Jensen DM; Cortina G; Fontana L; Ippoliti A
    Gastrointest Endosc; 2005 Feb; 61(2):232-40. PubMed ID: 15729231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
    Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
    Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: late outcomes from two randomized trials.
    Sie C; Bright T; Schoeman M; Game P; Tam W; Devitt P; Watson D
    Endoscopy; 2013 Nov; 45(11):859-65. PubMed ID: 24019134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
    Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
    Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endoscopic treatment of Barrett's oesophagus].
    Boyer J
    Ann Chir; 2006 Jan; 131(1):7-11. PubMed ID: 16376846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.